Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 87

1.

Blood pressure variability, impaired autonomic function and vascular senescence in aged spontaneously hypertensive rats are ameliorated by angiotensin blockade.

Sueta D, Koibuchi N, Hasegawa Y, Toyama K, Uekawa K, Katayama T, Ma M, Nakagawa T, Waki H, Maeda M, Ogawa H, Kim-Mitsuyama S.

Atherosclerosis. 2014 Sep;236(1):101-7. doi: 10.1016/j.atherosclerosis.2014.06.016. Epub 2014 Jun 26.

PMID:
25016364
[PubMed - in process]
2.

Telmisartan Exerts Sustained Blood Pressure Control and Reduces Blood Pressure Variability in Metabolic Syndrome by Inhibiting Sympathetic Activity.

Sueta D, Koibuchi N, Hasegawa Y, Toyama K, Uekawa K, Katayama T, Ma M, Nakagawa T, Ogawa H, Kim-Mitsuyama S.

Am J Hypertens. 2014 May 28. pii: hpu076. [Epub ahead of print]

PMID:
24871627
[PubMed - as supplied by publisher]
3.

Tissue inhibitor of metalloproteinase-3 knockout mice exhibit enhanced energy expenditure through thermogenesis.

Hanaoka Y, Yasuda O, Soejima H, Miyata K, Yamamoto E, Izumiya Y, Maeda N, Ohishi M, Rakugi H, Oike Y, Kim-Mitsuyama S, Ogawa H.

PLoS One. 2014 Apr 15;9(4):e94930. doi: 10.1371/journal.pone.0094930. eCollection 2014.

PMID:
24736588
[PubMed - in process]
Free PMC Article
4.

The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014).

Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ishimitsu T, Ito M, Ito S, Itoh H, Iwao H, Kai H, Kario K, Kashihara N, Kawano Y, Kim-Mitsuyama S, Kimura G, Kohara K, Komuro I, Kumagai H, Matsuura H, Miura K, Morishita R, Naruse M, Node K, Ohya Y, Rakugi H, Saito I, Saitoh S, Shimada K, Shimosawa T, Suzuki H, Tamura K, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Umemura S; Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension.

Hypertens Res. 2014 Apr;37(4):253-387. doi: 10.1038/hr.2014.20. No abstract available.

PMID:
24705419
[PubMed - in process]
5.

Sex differences in response to angiotensin II receptor blocker-based therapy in elderly, high-risk, hypertensive Japanese patients: a subanalysis of the OSCAR study.

Matsui K, Kim-Mitsuyama S, Ogawa H, Jinnouchi T, Jinnouchi H, Arakawa K; OlmeSartan Calcium Antagonists Randomized (OSCAR) Study Group.

Hypertens Res. 2014 Jun;37(6):526-32. doi: 10.1038/hr.2014.23. Epub 2014 Mar 6.

PMID:
24599010
[PubMed - in process]
6.

Rosuvastatin ameliorates early brain injury after subarachnoid hemorrhage via suppression of superoxide formation and nuclear factor-kappa B activation in rats.

Uekawa K, Hasegawa Y, Ma M, Nakagawa T, Katayama T, Sueta D, Toyama K, Kataoka K, Koibuchi N, Kawano T, Kuratsu J, Kim-Mitsuyama S.

J Stroke Cerebrovasc Dis. 2014 Jul;23(6):1429-39. doi: 10.1016/j.jstrokecerebrovasdis.2013.12.004. Epub 2014 Feb 12.

PMID:
24529602
[PubMed - in process]
7.

Apoptosis signal-regulating kinase 1 is a novel target molecule for cognitive impairment induced by chronic cerebral hypoperfusion.

Toyama K, Koibuchi N, Uekawa K, Hasegawa Y, Kataoka K, Katayama T, Sueta D, Ma MJ, Nakagawa T, Yasuda O, Tomimoto H, Ichijo H, Ogawa H, Kim-Mitsuyama S.

Arterioscler Thromb Vasc Biol. 2014 Mar;34(3):616-25. doi: 10.1161/ATVBAHA.113.302440. Epub 2013 Dec 26.

PMID:
24371084
[PubMed - indexed for MEDLINE]
8.

The authors reply.

Kim-Mitsuyama S, Ogawa H, Matsui K, Jinnouchi T, Jinnouchi H, Arakawa K.

Kidney Int. 2013 Nov;84(5):1047-8. doi: 10.1038/ki.2013.313. No abstract available.

PMID:
24172735
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Renal denervation prevents stroke and brain injury via attenuation of oxidative stress in hypertensive rats.

Nakagawa T, Hasegawa Y, Uekawa K, Ma M, Katayama T, Sueta D, Toyama K, Kataoka K, Koibuchi N, Maeda M, Kuratsu J, Kim-Mitsuyama S.

J Am Heart Assoc. 2013 Oct 14;2(5):e000375. doi: 10.1161/JAHA.113.000375.

PMID:
24125845
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Long-term renal denervation normalizes disrupted blood pressure circadian rhythm and ameliorates cardiovascular injury in a rat model of metabolic syndrome.

Katayama T, Sueta D, Kataoka K, Hasegawa Y, Koibuchi N, Toyama K, Uekawa K, Mingjie M, Nakagawa T, Maeda M, Ogawa H, Kim-Mitsuyama S.

J Am Heart Assoc. 2013 Aug 23;2(4):e000197. doi: 10.1161/JAHA.113.000197.

PMID:
23974905
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

The authors reply.

Kim-Mitsuyama S, Ogawa H, Matsui K, Jinnouchi T, Jinnouchi H, Arakawa K.

Kidney Int. 2013 Jul;84(1):215-6. doi: 10.1038/ki.2013.127. No abstract available.

PMID:
23812367
[PubMed - indexed for MEDLINE]
12.

Pretreatment with rosuvastatin protects against focal cerebral ischemia/reperfusion injury in rats through attenuation of oxidative stress and inflammation.

Ma M, Uekawa K, Hasegawa Y, Nakagawa T, Katayama T, Sueta D, Toyama K, Kataoka K, Koibuchi N, Kuratsu J, Kim-Mitsuyama S.

Brain Res. 2013 Jun 26;1519:87-94. doi: 10.1016/j.brainres.2013.04.040. Epub 2013 Apr 28.

PMID:
23632378
[PubMed - indexed for MEDLINE]
13.

Novel mechanism for disrupted circadian blood pressure rhythm in a rat model of metabolic syndrome--the critical role of angiotensin II.

Sueta D, Kataoka K, Koibuchi N, Toyama K, Uekawa K, Katayama T, Mingjie M, Nakagawa T, Waki H, Maeda M, Yasuda O, Matsui K, Ogawa H, Kim-Mitsuyama S.

J Am Heart Assoc. 2013 Apr 29;2(3):e000035. doi: 10.1161/JAHA.113.000035.

PMID:
23629805
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Voltage-dependent N-type Ca2+ channels in endothelial cells contribute to oxidative stress-related endothelial dysfunction induced by angiotensin II in mice.

Nishida M, Ishikawa T, Saiki S, Sunggip C, Aritomi S, Harada E, Kuwahara K, Hirano K, Mori Y, Kim-Mitsuyama S.

Biochem Biophys Res Commun. 2013 May 3;434(2):210-6. doi: 10.1016/j.bbrc.2013.03.040. Epub 2013 Mar 26.

PMID:
23537646
[PubMed - indexed for MEDLINE]
Free Article
15.

p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase.

Watanabe H, Miyamoto Y, Honda D, Tanaka H, Wu Q, Endo M, Noguchi T, Kadowaki D, Ishima Y, Kotani S, Nakajima M, Kataoka K, Kim-Mitsuyama S, Tanaka M, Fukagawa M, Otagiri M, Maruyama T.

Kidney Int. 2013 Apr;83(4):582-92. doi: 10.1038/ki.2012.448. Epub 2013 Jan 16.

PMID:
23325087
[PubMed - indexed for MEDLINE]
16.

ASK3 responds to osmotic stress and regulates blood pressure by suppressing WNK1-SPAK/OSR1 signaling in the kidney.

Naguro I, Umeda T, Kobayashi Y, Maruyama J, Hattori K, Shimizu Y, Kataoka K, Kim-Mitsuyama S, Uchida S, Vandewalle A, Noguchi T, Nishitoh H, Matsuzawa A, Takeda K, Ichijo H.

Nat Commun. 2012;3:1285. doi: 10.1038/ncomms2283.

PMID:
23250415
[PubMed - indexed for MEDLINE]
17.

An angiotensin II receptor blocker-calcium channel blocker combination prevents cardiovascular events in elderly high-risk hypertensive patients with chronic kidney disease better than high-dose angiotensin II receptor blockade alone.

Kim-Mitsuyama S, Ogawa H, Matsui K, Jinnouchi T, Jinnouchi H, Arakawa K.

Kidney Int. 2013 Jan;83(1):167-76. doi: 10.1038/ki.2012.326. Epub 2012 Oct 10.

PMID:
23051740
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Nanoparticle-mediated delivery of pioglitazone enhances therapeutic neovascularization in a murine model of hindlimb ischemia.

Nagahama R, Matoba T, Nakano K, Kim-Mitsuyama S, Sunagawa K, Egashira K.

Arterioscler Thromb Vasc Biol. 2012 Oct;32(10):2427-34. doi: 10.1161/ATVBAHA.112.253823. Epub 2012 Aug 9.

PMID:
22879581
[PubMed - indexed for MEDLINE]
Free Article
19.

Calcium channel blockers, more than diuretics, enhance vascular protective effects of angiotensin receptor blockers in salt-loaded hypertensive rats.

Yamamoto E, Kataoka K, Dong YF, Koibuchi N, Toyama K, Sueta D, Katayama T, Yasuda O, Ogawa H, Kim-Mitsuyama S.

PLoS One. 2012;7(6):e39162. doi: 10.1371/journal.pone.0039162. Epub 2012 Jun 14. Erratum in: PLoS One. 2013;8(12). doi:10.1371/annotation/dcf5bff7-1a2e-4f9d-8ea7-cde53f04284f.

PMID:
22720058
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Angiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patients.

Ogawa H, Kim-Mitsuyama S, Matsui K, Jinnouchi T, Jinnouchi H, Arakawa K; OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study Group.

Am J Med. 2012 Oct;125(10):981-90. doi: 10.1016/j.amjmed.2011.12.010. Epub 2012 Apr 14.

PMID:
22503610
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk